NeuroHELP Business
Product stage
Clinical Trial
Sector
Health Tech & Life SciencesMedical DevicesMedical Monitors
Target Customer
Industrial ManufacturingDiscrete IndustriesAerospaceHealthcare & Life SciencesHealthcareProviders
Core Technology
Semiconductors & ElectronicsWearablesArtificial IntelligenceMachine Learning
Tags (9)
epilepsymedical-devicesalert-systemartificial-intelligencehealthcare-providersneurologywearablechildrenalgorithms
NeuroHELP News
1 article
Researchers at Ben-Gurion University develop a device that predicts epileptic seizures
Researchers at Ben-Gurion University of the Negev (BGU) have developed a wearable device called Epiness that uses machine learning algorithms to predict the onset of seizures. The device will be licensed for further development by NeuroHelp, a startup founded by BGN Technologies. The device monitors EEG-based brain activity to detect and predict seizures, sending a warning message to the users smartphone. NeuroHelp is developing a prototype that will be assessed in clinical trials. The algorithm has reached a 97% accuracy rate. Epilepsy affects over 65 million people worldwide, and the device aims to help meet unmet medical needs in identifying upcoming seizures.
PartnersInvestment
NeuroHELP Team
Nadav Karni
Co-founder & CEO
Founder
Oren Shriki
Co-founder & CTO
Founder
Hadar Ron
Co-founder and Active Chair Person
Founder
Shay Ben Sasson
Co-founder and VP R&D
Founder
Employee Info
| Employees (range) | 11-50 |
| Exact count | 12 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.